Skip to content
JAMA Ophthalmology Author Interviews cover art

All episodes

JAMA Ophthalmology Author Interviews, 133 episodes. Page 2 of 2.

#
Title
101

Outcomes of the Veterans Affairs Low Vision Intervention Trial II

102

Binocular iPad Game vs Patching for Treatment of Amblyopia in Children

103

Axial Length and Risk of Uncorrectable Visual Impairment for Myopia

104

Interventions to Improve Trabeculectomy Surgery Follow-up in Rural China

105

Industry Payments and Physician Anti–Vascular Endothelial Growth Factor Prescribing

106

Gender Representation in Industry Ties in Ophthalmology

107

Awareness and Knowledge of Emergent Ophthalmic Disease

108

Hepatic Ultrasonography for Surveillance in Uveal Melanoma

109

Associations Between Carotenoid Intake and AMD

110

Proposed Minimum Standard Set of Outcome Measures for Cataract Surgery

111

Cost-Related Medication Nonadherence and Cost Savings in Patients With Glaucoma

112

Prediction of Juvenile-Onset Myopia

113

Retinal Nerve Fiber Layer Loss and Quality of Life in Glaucoma

114

Refractive Outcomes After Bevacizumab Monotherapy

115

Effect of a Teleretinal Screening Program on Eye Care Use and Resources

116

Enhanced Vitreous Imaging Technique With Spectral-Domain Optical Coherence Tomography for Evaluation of Posterior Vitreous Detachment

117

Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

118

Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

119

Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

120

Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

121

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

122

Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

123

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

124

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

125

The Ophthalmic Practice of the Future

126

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

127

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

128

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

129

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma